A citation-based method for searching scientific literature

Adam D Cohen, Alfred L Garfall, Edward A Stadtmauer, J Joseph Melenhorst, Simon F Lacey, Eric Lancaster, Dan T Vogl, Brendan M Weiss, Karen Dengel, Annemarie Nelson, Gabriela Plesa, Fang Chen, Megan M Davis, Wei-Ting Hwang, Regina M Young, Jennifer L Brogdon, Randi Isaacs, Iulian Pruteanu-Malinici, Don L Siegel, Bruce L Levine, Carl H June, Michael C Milone. J Clin Invest 2019
Times Cited: 304



Michael C Milone, Jonathan D Fish, Carmine Carpenito, Richard G Carroll, Gwendolyn K Binder, David Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers, Dario Campana, James L Riley, Stephan A Grupp, Carl H June. Mol Ther 2009
Times Cited: 740




List of shared articles



Times cited

Rapid manufacturing of non-activated potent CAR T cells.
Saba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, Jai Patel, John Leferovich, Marilia Pinzone, Feng Shen, Katherine D Cummins, Gabriela Plesa, Vito Adrian Cantu,[...]. Nat Biomed Eng 2022
1

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells.
Julie O'Neal, Julie K Ritchey, Matthew L Cooper, Jessica Niswonger, L Sofía González, Emily Street, Michael P Rettig, Susan W Gladney, Leah Gehrs, Ramzi Abboud,[...]. Leukemia 2022
0

sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma.
Katja Seipel, Naomi Porret, Gertrud Wiedemann, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst. Curr Issues Mol Biol 2022
0

Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma.
Lorena Perez-Amill, Guillermo Suñe, Asier Antoñana-Vildosola, Maria Castella, Amer Najjar, Jaume Bonet, Narcis Fernández-Fuentes, Susana Inogés, Ascensión López, Clara Bueno,[...]. Haematologica 2021
13


Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges.
Binod Dhakal, Parameswaran N Hari, Saad Z Usmani, Mehdi Hamadani. Bone Marrow Transplant 2021
8

Pharmacology of Chimeric Antigen Receptor-Modified T Cells.
Edward Z Song, Michael C Milone. Annu Rev Pharmacol Toxicol 2021
3

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.
Christina Amatya, Melissa A Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi, Stephen M Hewitt, Steven A Feldman, James N Kochenderfer. Mol Ther 2021
21

An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity.
Seth Carbonneau, Sujata Sharma, Liaomin Peng, Vaisakh Rajan, Dominik Hainzl, Martin Henault, Chian Yang, Jacob Hale, Janine Shulok, John Tallarico,[...]. Cell Chem Biol 2021
4

Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma.
Marcin Jasiński, Grzegorz W Basak, Wiesław W Jedrzejczak. Front Immunol 2021
10